Join to View Full Profile
3303 S Bond AvePortland, OR 97239
Phone+1 503-494-6594
Fax+1 503-494-5385
Dr. Thawani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Thoracic oncologist interested in patient care, drug development and translational oncology
Education & Training
Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 2020 - 2023
Maimonides Medical CenterResidency, Internal Medicine, 2017 - 2020
Delhi University College of Medical SciencesClass of 2014
Certifications & Licensure
IL State Medical License 2023 - 2026
OR State Medical License 2020 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow Teaching Award OHSU Internal Medicine Residency, 2022
- Fellow Research Award OHSU Internal Medicine, 2022
- Abstract Achievement Award American Society of Hematology, 2021
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- HSR25-147: Time Toxicity of Different Frontline Regimens in EGFR Mutated Non-Small Cell Lung Cancer.Padma Sri Katikaneni, Bowon Joung, Won Jin Jeon, Neha Agrawal, Akshit Chitkara
Journal of the National Comprehensive Cancer Network. 2025-03-28 - Rationale for Investigation of Neoadjuvant Chemoimmunotherapy Before Chemoradiation in Unresectable Stage III Non-Small Cell Lung Cancer.Rajat Thawani, Christine M Bestvina, Everett E Vokes, Aditya Juloori
Journal of Clinical Oncology. 2025-03-27 - 1 citationsTrends in complexity of single-agent and combination therapies for solid tumor cancers approved by the US Food and Drug Administration.Emerson Y Chen, Manoj Rai, Yash Tadikonda, Preeyam Roy, Dakota W Nollner
The Oncologist. 2025-03-10
Press Mentions
Foreign PracticeNovember 17th, 2014
New Imaging Technology May Help Predict Aggressiveness of Lung CancerOctober 7th, 2018
A New Generation of Physicians Matures into Patient Safety LeadershipNovember 26th, 2020- Join now to see all
Grant Support
- ROS1 in chemopreventionNL Tartar Trust2022–Present
- Strategies to bypass intrinsic resistance in ROS1 rearranged non-small cell lung cancerMedical Research Foundation of Oregon2022–2023
- Resident Research grantMaimonides Research and Development Foundation2017–2018
- CIR Wellness GrantCommittee of Interns and ResidentsPresent
Committees
- Member, Global Policy and Partnerships Committee 2024 - Present
Professional Memberships
- Member
- Member
- Society for Immunotherapy of CancerMember
- International Association for the Study of Lung CancerMember
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
